PubMed HealthSearch

SEARCH · PubMed Health

Results for “Republic of Belarus”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Mutant forms of erythrocyte glucose 6-phosphate dehydrogenase in Ashkenazi. Description of two new variants: G6PD Kirovograd and G6PD Zhitomir.

Two new variants of erythrocyte glucose 6-phosphate dehydrogenase are discovered in 3 unrelated Ashkenazi Jew patients with severe deficiency of enzyme. Both variants have a resemblance to 2 other variants in Ashkenazi: G6PD Boston and G6PD Kilgore, but have a significantly higher affinity for substrates and their analogues and are not associated with chronic hemolytic disease. Probably, all 4 variants arise from two ancestral mutations.

Genetic Variation

[Characteristics of two new mutant forms of erythrocyte glucose-6-phosphate dehydrogenase: "Kirovograd" G6PD and "Zhitomir" G6PD].

The paper comprises the description of properties of three mutant forms of glucoso-6-phosphate dehydrogenase characterized according the WHO program. Preparations of the enzymes were isolated from erythrocytes of patients with G6PD deficiency from three unrelated to one another Ashkenasi families coming from the Ukraine and from Byelorussia. Two new variants of G6PD hitherto never described in the literature were discovered. These variants were designated as "Kirovograd" and "Zhitomir" after the towns the probands came from. The properties of purified enzymes revealed by the methods of the WHO program were as follows: the variant "Kirovograd" has a normal electrophoretic mobility in tris and TEB buffers and 98% of the normal in phosphate buffer. KM for G6P is 6,54; KM for NADP--2,19. It is characterized by a reduced thermostability and by an acute peak of activity at pH 8,5. The variant "Zhitomir" has 90-98% of the normal electrophoretic mobility in TEB buffer and 78-84% in phosphate buffer. KM for G6P is 5,4-8,3. KM for NADP is 1,4-3,1; with deoxyG6P is 50% and with deaminoNADP is 35%. It is also characterized with a reduced thermostability, while the curve of the dependence of its activity on pH has two peaks. Both variants are perfectly inactive with erythrocytes and thus should be assigned to the second group of the mutants variants of G6PD. The comparison of these variants to other variants encountered in the same national group revealed that they resemble certain quantitative variations.

Catalysis

[Diabetic feto- and embryopathies].

The present article gives an analysis of available literature and the authors' own findings. Perinatal mortality of progeny of mothers suffering from diabetes mellitus may be caused both by embryopathy and antenatal fetopathy. The authors did not observe diabetic gameto- and blastopathies and no indications to their existance was found in literature, although some investigators admit the possibility of genetic implication in the pathology of progeny of parents with diabetes mellitus. In the progeny of mothers suffering from diabetes mellitus among congenital malformations which allow further intrauterine development and even extrauterine life, according to literature data most often there were observed malformations of the skeleton (37%), cardiovascular system malformations (24%) and those of the nervous system (14%). In all observations of the authors there were found congenital malformations of the bone system not infrequently in combination with other congenital defects. The main features of diabetic fetopathy appear in the last third of pregnancy, and therefore it may be considered as late antenatal fetopathy. The term "diabetic children" applied by some authors to children with diabetic fetopathy should be avoided since it may be erroneously understood as diabetes mellitus. In the majority of cases quite different mechanisms underlie these conditions: hypofunction of the islet apparatus of the pancreas in diabetes mellitus, and its hypofunction in diabetic fetopathy. Diagnosis of diabetic feto- and embryopathies is always based on both clinical and morphological data.

Abnormalities, Multiple

[Diagnosis of malignant neoplasms in ambulatory practice (based on data from a random examination)].

The ambulatory-polyclinic network is the first step of the patient's address and investigation for basic forms of malignant tumors. As a result of the analysis of 2361 ambulatory case reports, it was found that in 70.7% of cases the correct diagnosis was established not by medical specialists of the outpatient clinics but in oncological institution where these patients were directed for a consultation.

Adult